| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,003 | 3,182 | 3,478 | 4,438 | | Cost of Revenue | 1,195 | 1,417 | 1,409 | 1,607 | | | Gross Profit | 1,808 | 1,765 | 2,069 | 2,831 | | | Operating Expenses | | Research Development | 2,010 | 2,432 | 2,194 | 3,573 | | Selling General and Administrative | 2,666 | 3,218 | 3,703 | 3,508 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,868) | (3,886) | (3,829) | (4,249) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18 | 48 | 36 | 54 | | Earnings Before Interest And Taxes | (2,850) | (3,837) | (3,793) | (4,195) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,850) | (3,837) | (3,793) | (4,195) | | Income Tax Expense | 10 | 11 | 10 | 11 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,859) | (3,848) | (3,803) | (4,206) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,859) | (3,848) | (3,803) | (4,206) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,859) | ($3,848) | ($3,803) | ($4,206) |
|
0.51% Nasdaq 
0.07 (2.64%) 
Income Statement
